The genomic and immunologic profiles of pure pulmonary sarcomatoid carcinoma in Chinese patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The genomic and immunologic profiles of pure pulmonary sarcomatoid carcinoma in Chinese patients

Published:2021-03 Issue: Volume:153 Page:66-72
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Zhou Fei,Huang Yan,Cai Weijing,Li Jin,Su Chunxia,Ren Shengxiang,Wu Chunyan,Zhou Caicun

Funder

Shanghai Tongshu Biotechnology Co., Ltd

Geneplus-Beijing Institute

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference38 articles.

1. Outcomes of sarcomatoid carcinoma of the lung: a Surveillance, Epidemiology, and End Results Database analysis;Yendamuri;Surgery,2012

2. Sarcomatoid lung cancer (spindle/giant cells): an aggressive disease?;Venissac;J. Thorac. Cardiovasc. Surg.,2007

3. Sarcomatoid carcinoma of the lung: a predictor of poor prognosis;Martin;Ann. Thorac. Surg.,2007

4. Clinicopathologic outcomes of curative resection for sarcomatoid carcinoma of the lung;Park;Oncology,2011

5. Characteristics and prognostic analysis of 69 patients with pulmonary sarcomatoid carcinoma;Lin;Am. J. Clin. Oncol.,2016

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heterogeneity in advanced pulmonary sarcomatoid carcinoma and its efficacy to immune checkpoint inhibitors;European Journal of Cancer;2024-09

2. Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review;Translational Lung Cancer Research;2024-03

3. Case report: Successful treatment of advanced pulmonary sarcomatoid carcinoma with BUBIB-ALK rearrangement and KRAS G12C mutation by sintilimab combined with anlotinib;Frontiers in Oncology;2024-02-13

4. Role of immunotherapy in pulmonary sarcomatoid carcinoma: review of current approaches and related biomarkers;Therapeutic Advances in Medical Oncology;2024-01

5. Effectiveness and Safety of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in Pulmonary Sarcomatoid Carcinoma;JTO Clinical and Research Reports;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3